IN8bio, Inc.
INAB
$0.1449
$0.01219.11%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 11.89M | 11.12M | 4.00M | 10.22M | 13.02M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 410.00K | 1.16M | 2.53M | 1.94M | 2.20M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 427.00K | 298.00K | 177.00K | 529.00K | 539.00K |
Total Current Assets | 12.73M | 12.58M | 6.70M | 12.68M | 15.76M |
|
|||||
Total Current Assets | 12.73M | 12.58M | 6.70M | 12.68M | 15.76M |
Net Property, Plant & Equipment | 6.60M | 7.83M | 8.50M | 9.24M | 9.22M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 544.00K | 541.00K | 764.00K | 579.00K | 576.00K |
Total Assets | 19.87M | 20.94M | 15.97M | 22.50M | 25.55M |
|
|||||
Total Accounts Payable | 575.00K | 389.00K | 1.14M | 1.44M | 1.41M |
Total Accrued Expenses | 1.15M | 1.05M | 769.00K | 1.53M | 895.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.24M | 1.65M | 1.73M | 1.78M | 1.54M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 2.96M | 3.08M | 3.64M | 4.76M | 3.84M |
|
|||||
Total Current Liabilities | 2.96M | 3.08M | 3.64M | 4.76M | 3.84M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 3.04M | 3.38M | 3.74M | 4.12M | 4.18M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 5.99M | 6.47M | 7.38M | 8.88M | 8.02M |
|
|||||
Common Stock & APIC | 141.08M | 136.13M | 124.08M | 122.03M | 117.31M |
Retained Earnings | -127.21M | -121.66M | -115.50M | -108.41M | -99.78M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 13.88M | 14.48M | 8.59M | 13.62M | 17.53M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 13.88M | 14.48M | 8.59M | 13.62M | 17.53M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 13.88M | 14.48M | 8.59M | 13.62M | 17.53M |
|